Skip to main content
Clinical Trials/NCT05693753
NCT05693753
Recruiting
Not Applicable

Coronally Advanced Flap With Xenogenic Collagen Matrix or Autogenous Connective Tissue Graft for the Treatment of Multiple Adjacent Gingival Recessions: a Randomized Controlled Trial

University of Turin, Italy1 site in 1 country40 target enrollmentFebruary 2, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gingival Recession, Generalized
Sponsor
University of Turin, Italy
Enrollment
40
Locations
1
Primary Endpoint
Mean Recession Reduction (RecRed)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The primary aim of this study is to evaluate whether the use of a xenogenic collagen matrix (XCM) for the treatment of multiple adjacent gingival recessions (MAGRs) with a multiple coronally advanced flap technique (mCAF) achieves better results than the use of an autologous connective tissue graft (CTG) in terms of recession reduction (primary outcome) and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage). Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling, bleeding). The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF with XCM is not inferior to CTG in terms of recessions reduction and secondary clinical variables, and superior regarding to PROMs.

Registry
clinicaltrials.gov
Start Date
February 2, 2023
End Date
December 2, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Turin, Italy
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • At least 18 years old and able to sign informed consent
  • At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without interproximal exposure of the CEJ (interdental gingival recession), at least one with a depth of ≥2mm with indication for root coverage treatment
  • A minimum of 4 adjacent teeth (including the ones to be treated) in the region of interest
  • Available to attend study related procedures (including follow-up visits)

Exclusion Criteria

  • Systemic diseases/medications which could influence the outcome of the therapy (e.g., uncontrolled diabetes mellitus);
  • Current smokers (self-reported, any type of smoking), users of chewing tobacco, and drug/alcohol abusers;
  • Pregnant or nursing women;
  • History of previous periodontal surgery (mucogingival or other) on the teeth to be included;
  • Furcation involvement in the teeth to be included;
  • Presence of severe tooth malposition, rotation or clinically significant extrusion in the teeth to be treated;
  • Presence of fixed or removable prosthesis in the area to be treated

Outcomes

Primary Outcomes

Mean Recession Reduction (RecRed)

Time Frame: 6 months; 1 year

Mean changes in mm in recession depth between baseline and 1-year

Secondary Outcomes

  • Mean Root Coverage (MRC)(6 months; 1 year)
  • Post-operative morbidity (pain, swelling, discomfort)(14 days)
  • Keratinised tissue height (KTH) changes(6 months; 1 year)
  • Complete Root Coverage (CRC)(6 months; 1 year)

Study Sites (1)

Loading locations...

Similar Trials